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Abstract
Distal Xq duplications refer to chromosomal disorders resulting from involvement of the long arm
of the X chromosome (Xq). Clinical manifestations widely vary depending on the gender of the
patient and on the gene content of the duplicated segment. Prevalence of Xq duplications remains
unknown. About 40 cases of Xq28 functional disomy due to cytogenetically visible rearrangements,
and about 50 cases of cryptic duplications encompassing the MECP2 gene have been reported. The
most frequently reported distal duplications involve the Xq28 segment and yield a recognisable
phenotype including distinctive facial features (premature closure of the fontanels or ridged
metopic suture, broad face with full cheeks, epicanthal folds, large ears, small and open mouth, ear
anomalies, pointed nose, abnormal palate and facial hypotonia), major axial hypotonia, severe
developmental delay, severe feeding difficulties, abnormal genitalia and proneness to infections. Xq
duplications may be caused either by an intrachromosomal duplication or an unbalanced X/Y or X/
autosome translocation. In XY males, structural X disomy always results in functional disomy. In
females, failure of X chromosome dosage compensation could result from a variety of mechanisms,
including an unfavourable pattern of inactivation, a breakpoint separating an X segment from the
X-inactivation centre in cis, or a small ring chromosome. The MECP2 gene in Xq28 is the most
important dosage-sensitive gene responsible for the abnormal phenotype in duplications of distal
Xq. Diagnosis is based on clinical features and is confirmed by CGH array techniques. Differential
diagnoses include Prader-Willi syndrome and Alpha thalassaemia-mental retardation, X linked
(ATR-X). The recurrence risk is significant if a structural rearrangement is present in one of the
parent, the most frequent situation being that of an intrachromosomal duplication inherited from
the mother. Prenatal diagnosis is performed by cytogenetic testing including FISH and/or DNA
quantification methods. Management is multi-specialist and only symptomatic, with special attention
to prevention of malnutrition and recurrent infections. Educational and rehabilitation support
should be offered to all patients.
Disease name: Xq duplications, Xq functional disomy
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Background – epidemiology
Duplications of the long arm of chromosome X (Xq)
include intrachromosomal duplications and partial diso-
mies/trisomies resulting from unbalanced translocations
with an autosome or with a chromosome Y. As for other
X-linked disorders, X-inactivation plays a major role in
clinical expression of these chromosomal imbalances
with usually milder symptoms in females than in males.
Large, cytogenetically visible duplications of Xq are rare
[1]. They implicate more often the distal Xq27-qter region
[2-5]. Recently, CGH array techniques allowed the detec-
tion of smaller imbalances. Duplications including the
MECP2 gene in Xq28 are of major concern, with about 47
cases reported in the literature. Now it seems clear that the
MECP2 gene is the most important dosage-sensitive gene
responsible for neurologic impairment in patients with
duplications of the distal part of chromosome Xq. After a
short reminder of X-inactivation mechanism, and general
considerations about Xq duplications, we will focus
mainly on Xq distal duplications.
Prevalence of Xq duplications is presently unknown.
About 40 cases of Xq functional disomy due to cytogenet-
ically visible rearrangements, and about 50 cases of cryptic
duplications encompassing the MECP2 gene have been
reported.
Functional disomy: definition and role of X inactivation 
(Figures 1 and 2)
X chromosome inactivation (XCI) is the epigenetic mech-
anism through which mammalian cells achieve gene dos-
age compensation between male (XY) and female cells
(XX). Most X-linked genes are therefore expressed in a
similar level in females as in males. Functional disomy
(FD) is the double expression of X-linked genes compared
to their normal level. In males, all structural duplications
lead to FD. In females, the X structural imbalances may
lead to a variable phenotype depending on the X-inactiva-
tion pattern.
X-inactivation of one X chromosome occurs early in
female development and is initiated from the X-Inactiva-
tion Centre (XIC), located in Xq13 on the proximal part
of the long arm, and that contains the XIST gene. As the
choice of the inactive X is a random process, each female
is a functional mosaic for two cell populations [6]. The
number of cells that have inactivated the same X chromo-
some follows a normal distribution around a mean of
50:50. In most studies, skewing and extreme skewing are
arbitrarily defined as greater than or equal to 75%, and
greater than or equal to 90% of cells expressing the same
X chromosome, respectively. The later value is usually
retained as significant for morbid manifestations. Struc-
tural abnormalities of the X chromosome such as large
deletions, duplications, and unbalanced X/autosome
translocations result in skewed patterns of inactivation,
with the abnormal X chromosome being inactive in most
or all cells [7]. Conversely, in about 95% of balanced
t(X;A), the normal X chromosome is inactivated in all
cells [8]. This pattern preserves the balance of expression
from the X and from the autosome (Figure 2b). In some
cases, the derivative containing XIC is inactivated. Conse-
quently, these cells are functionally disomic for a part of
the X chromosome. The presence of disomic cells was
highly prevalent in translocations with breakpoints at
Xp22 and Xq28, even though spreading of X inactivation
onto the adjacent autosomal segment was noted in most
of these cases [8,9]. This pattern of inactivation is usually
associated with an abnormal phenotype. The outcome of
the selection process against the functional disomy X
seems to be the major determinant of the clinical status in
most patients with balanced X-autosome translocations
[10].
It is noteworthy that more than 15% of genes on the
human X chromosome, including many without func-
tional equivalent on the Y, escape from XCI. They are
mainly located in the pseudo-autosomal regions at each
end of the X chromosome but a small number of them are
found outside these regions [11].
X-linked disease genes
A large number of disease conditions have been associ-
ated with the X chromosome because the phenotypic con-
sequences of a recessive mutation are revealed directly in
the hemizygous male. The X chromosome contains
approximately 1,100 genes and is associated with over
300 Mendelian conditions. Both the X and Y chromo-
somes have a remarkable enrichment of genes involved in
gonadogenesis and gametogenesis. X-linked mental retar-
dation (XLMR) is a common cause of inherited intellec-
tual disability with an estimated prevalence of about 1/
1,000 males [12]. In a recent review, Chiurazzi et al. listed
215 XLMR conditions including 149 with specific clinical
findings of which in 82 the causal MRX gene has been
identified. Among these genes, 47 were localised on the
long arm [13]. Besides the FMR1 gene responsible for the
fragile X mental retardation syndrome, the chromosomal
region Xq27.3-qter harbours several genes that have been
shown to be responsible for syndromic and non-syndro-
mic forms of XLMR (e.g. IDS, ABCD1, L1CAM, MECP2,
FLNA, IKBKG, DKC,1 FMR2, GDI1, SLC6A8, and MECP2)
[14]. This region is at high risk for genomic instability and
several of these genes are implicated in genomic disorders
due to nonallelic homologous recombination between
low copy repeats [15].
Consequences of over-expression of X-linked genes is not
well known, with the exception of the PLP1 gene (whose
duplication is responsible for the Pelizaeus-MerzbacherOrphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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syndrome (OMIM 312080)), and, more recently, the
MECP2  gene.  MECP2  selectively binds to methylated
DNA and mutations in the MECP2 gene cause the autism-
spectrum neurodevelopmental disorder Rett syndrome
(OMIM 312750). Its primary role was thought to form a
link between DNA methylation, histone acetylation and
co-repressor molecules. Evidence is now accumulating for
a more expanded role of MECP2 as a multifunctional pro-
tein involved in the modulation of chromatin structure by
different mechanisms. The MECP2 gene is expressed in
many tissues, but expression is highest in the brain. Dur-
ing development, MECP2 expression is very low or absent
in immature neurons, then it increases during neuronal
maturation and is highest in post-mitotic post migratory
neurons. Mild over-expression of wild-type MECP2 pro-
tein induced neurodevelopmental abnormalities in trans-
genic mice, and duplication of the MECP2 gene causes
mental retardation in human males as discussed below.
Schematic representation of a Xq duplication transmission Figure 1
Schematic representation of a Xq duplication transmission. Active X and Y chromosomes are in grey, inactive X is 
striped in black. A yellow star represents XIC. a) normal XY chromosomes; b) Xq duplication in male leading to Xq functional 
disomy, associated with an abnormal phenotype; c) Xq duplication in female with inactivation pattern skewed towards the 
duplicated X, associated with a normal phenotype; d) Xq duplication in female with inactivation pattern skewed towards the 
normal X leading to Xq functional disomy, associated with an abnormal phenotype.Orphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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Clinical description
Clinical manifestations vary depending on the gender and
on the gene content of the duplicated segment.
Clinical manifestations in males
Distal Xq duplications are the more frequently reported.
In particular, the Xq26–q28 chromosome region yields a
recognisable phenotype including distinctive facial fea-
tures, major axial hypotonia, severe developmental delay,
severe feeding difficulties, abnormal genitalia and prone-
ness to infections [2,4,5,16-18]. In details, these patients
present:
- Growth: prenatal and postnatal growth retardation,
microcephaly
- Dysmorphism: premature closure of the fontanels or
ridged metopic suture, brad face with full cheeks, epi-
canthal folds, large ears, small and open mouth, ear
anomalies, pointed nose, abnormal palate and facial
hypotonia are the most common facial features
- Psychomotor retardation: severe mental retardation,
absence or severely retarded speech
- Major axial hypotonia
- Spasticity
- Malformations: genitalia malformations including
hypoplasic genitalia, hypospadias and/or cryptorchidism
are the more frequent malformations
- Abnormal fingers and toes have been reported
- Others frequent clinical manifestations: severe feeding
difficulties with gastro oesophageal reflux, excessive
drooling, seizures, recurrent infections.
Proximal Xq duplications are more rarely reported. They
represent an heterogeneous group of patients with varia-
ble breakpoints, most of them studied only by banding
karyotyping, with some recent exceptions [1,19]. Patients
show craniofacial dysmorphism, brain and neurologic
abnormalities such as aberrant brain myelination, hypot-
onia, mental, psychomotor and growth retardation, feed-
ing issues, hypoplasic genitalia.
Table 1 presents clinical findings found in three groups of
patients, namely Xq12q24 duplications, Xq26-qter dupli-
cations (or functional disomy), and MECP2  interstitial
microduplications.
Schematic representation of a t(X;A) transmission Figure 2
Schematic representation of a t(X;A) transmission. Autosomes are blue, active X chromosome and Y chromosome are 
grey, inactive X chromosome is striped in black. Top: balanced t(X;A) in the mother, with usual pattern of inactivation (normal 
X inactivated). Transmission in male: a) normal; b) balanced translocation; c) unbalanced translocation with derivative auto-
some, leading to functional X disomy; d) unbalanced translocation with derivative X, leading to partial X monosomy and partial 
autosomal trisomy; a and b are associated to a normal phenotype, c and d to an abnormal phenotype. Transmission in female: 
a) normal; b) balanced translocation with normal X inactivated; c) unbalanced translocation with derivative autosome, leading 
to partial autosomal monosomy and to functional X disomy; d) unbalanced translocation with derivative X leading to partial X 
monosomy and partial autosomal trisomy; e) balanced translocation with rare inactivation pattern (der(X) inactivated) leading 
to functional disomy and potential inactivation spreading to translocated autosomal genes; a and b are associated to a normal 
phenotype; c, d and e to an abnormal phenotype.Orphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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Several clinical symptoms are common to the three
groups, despite different gene content. However, these
clinical findings are often non-specific, such as hypotonia,
psychomotor delay, feeding problems and genital hypo-
plasia. Recurrent respiratory infections, especially recur-
rent pneumonia, help to distinguish Xq28 functional
disomy (including MECP2  duplication) from other
XLMR-hypotonia syndromes. The recurrent infections
might result from the increased dosage of the IRAK1 or
IKBKG genes generally present in the duplicated region
[20].
Clinical manifestations in female
Most Xq duplications observed in males are inherited
from a mother with normal or near normal phenotype.
Less frequently, Xq duplications may be found by karyo-
typing in manifesting females studied because of mental
retardation. The most frequent manifestations found in
these patients are short stature, developmental delay,
Table 1: Comparison of clinical symptoms observed in three groups of patients with Xq duplications.
Xq21q24 DF* Xq26.3qter DF** MECP2 duplication ***
Number of cases 12 21 47
Caesarean section 0/1 8/14 nr
Growth
Growth retardation 9/10 17/19 2/3
Microcephaly 4/5 19/19 5/39
Facial dysmorphism
Prominent metopic suture nr 5/15 nr
Epicanthus fold nr 5/6 1/8
Large ears nr 9/12 4/20
Small mouth nr 11/13 6/20
Abnormal palate/maxillar alveolus nr 13/14 nr
Facial hypotonia nr 3/4 19/28
Neurologic outcome
Hypotonia 11/11 19/19 29/32
Developmental delay 12/12 19/19 47/47
Absent or delayed speech nr 11/14 46/47
Never walked or limited walking nr 12/14 21/34
Spacticity nr 3/4 17/21
Seizures nr 6/16 22/42
Malformations
Hypoplastic genitalia/cryptorchidism 11/11 15/19 5/10
Others
Severe feeding problems 9/9 10/14 15/29
Gastroesophageal reflux nr 4/7 13/17
Constipation nr 5/5 nr
Small feet nr 8/8 nr
Digital abnormalities 5/5 13/19 6/20
Recurrent infections 2/2 15/17 33/40
nr : not recorder
* modified from Cheng SF et al.[1] and Gabbett et al.[19]
** modified from Sanlaville et al.[5] and Smyk et al.[20]
*** modified from Ariani et al.[27], Meins et al.[28], Van Esch et al[26]., Freiz et al.[29], del Gaudio et al.[30], Madrigal et al.[31], and Smyk et al.[20].Orphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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facial dysmorphism and gonadal dysgenesis [21,22].
Body asymmetry may be present corresponding to func-
tional mosaicism. In the manifesting females, the X-inac-
tivation pattern is usually at random and this explains the
clinical manifestations. In rare cases, a favourable skewed
X-inactivation is observed. For these cases, other explana-
tions such as local escape from inactivation, expression of
recessive genes from the active X, or disruption of a gene
by the rearrangement have been suggested to explain the
abnormal phenotype [23,24]. Also a critical region for
gonadal dysgenesis has been suggested to be present in
Xq13q26 [25]. For duplications resulting from unbal-
anced t(X;A), the X-translocated segment separated from
its corresponding XIC cannot be inactivated, and abnor-
mal phenotype is fully expressed. In this rare situation, a
phenotype as severe as in males is observed in female
patients, with microcephaly, seizures and severe mental
retardation [5].
Specific phenotypes
Small duplications detected using array comparative
genomic hybridization (array CGH) and encompassing
only one or a few genes allow description of some more
specific phenotypes due to over-expression of individual
genes. The most striking example is the MECP2  gene
which prove to be the major gene implicated in Xq26-qter
duplications.
MECP2 duplication
Recently, array CGH and quantitative polymerase chain
reaction (PCR) allowed detection of submicroscopic Xq28
interstitial duplications. These microduplications are var-
iable in size, ranging from 0.2 to 2.2 Mb, but consistently
include MECP2 and L1 cell adhesion molecule (L1CAM),
as well as intervening genes [26]. To date, 47 affected indi-
viduals from 24 different families have been reported
[20,26-31]. The patients manifested severe mental retar-
dation, absent or limited speech, progressive neurologic
problems (such as spasticity and seizures), axial and facial
hypotonia, mild and non-specific facial dysmorphism,
and severe recurrent respiratory infection overlapping
with characteristics described in patients with larger
Xq27–q28 terminal duplications [26,30].
Collective data of previous studies suggest that increased
MECP2 gene copy number is mainly responsible for the
neurodevelopmental phenotypes in these patients
[20,26,29,30]. Moreover, mice with over-expression of
mecp2 have severe motor dysfunction [32] and progressive
neurologic decline [33]. In addition, Del Gaudio et al.
found  MECP2  triplication in one patient with a more
severe phenotype [30]. Additionally, a non-pathogenic
duplication of Xq28 that does not include the MECP2
gene has recently been reported [34].
SRY (sex determining region Y)-box 3 (SOX3) duplication
In 2005, Stankiewicz et al. reported a family in which five
females presented with short stature, speech and language
problems, hearing impairment, and several dysmorphic
features associated with a 7.5-Mb duplication of Xq26.2–
q27.1 that encompassed or disrupted the SOX3 gene [35].
SOX3 gene has previously been suggested as a candidate
gene in a female with moderate to severe mental retarda-
tion, seizures and hypothyroidism and del(X)(q26.3–
q27.3) [36]. At the same time, Woods et al. identified a
685 kb submicroscopic duplication of Xq27.1 containing
the SOX3 gene in two maternal half males sibs with X-
linked panhypopituitarism [37]. Brain magnetic reso-
nance imaging (MRI) showed anterior pituitary hypopla-
sia, ectopic posterior pituitary, and absent infundibulum.
They concluded that both over- and underdosage of SOX3
are associated with similar phenotypes, consisting of
infundibular hypoplasia and hypopituitarism but not
necessarily mental retardation.
Oligophrenin 1 (OPHN1) duplication
Recently, using oligonucleotide array CGH, Bedeschi et al.
reported a familial chromosome duplication spanning
about 800 kb of genomic DNA encompassing the YIPF6,
STARD8  and  OPHN1  genes. The male proband had
microcephaly, a distinct facial appearance, severe mental
retardation and language impairment [38]. OPHN1 muta-
tions have been reported in patients with moderate to
severe mental retardation, myoclonic-astatic epilepsy,
ataxia, cerebral hypoplasia strabismus and hypogenital-
ism [39]. The observation of Bedeschi et al., stressed the
interest of high resolution array CGH to delineate new
clinical phenotype secondary to small chromosome
abnormalities, in particular duplication.
Proteolipid protein 1 (PLP1) duplication
Microduplications encompassing the PLP1 gene have also
been reported with a clinical phenotype evocative of Peli-
zaeus-Merzbacher disease (PMD) [40]. Pelizaeus-Merz-
bacher disease (OMIM 312080) is a very rare X-linked
recessive inherited leukodystrophy with prevalence esti-
mated at 1 out of 400,000 birth. The disease occurs as an
early motor development impairment marked by hypoto-
nia associated with nystagmus, ataxochoreic movements
of the axis and limbs, especially during the first 2 years of
life. Symptoms often progress slowly until adolescence.
PMD is caused by mutation in the gene encoding the pro-
teolipid protein-1 (PLP1) gene. Complete duplication of
the PLP1 gene on Xq22 is the cause of 60–70% of PMD
cases, whereas deletions of this gene as well as point muta-
tions in coding or splice site regions are involved in most
of the remaining cases [41].Orphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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Other genes duplications
In addition, Froyen et al., using array CGH, reported two
other small Xq duplications. The first one is a duplication
of about 0,8 Mb at Xq22 containing 15 annotated genes.
They proposed the NXF5 gene, including in the dupli-
cated region, to explain mental retardation. In fact,
increased dosage of NXF5 might disturb storage levels of
particular mRNA in neurons. Nevertheless, expression lev-
els of NXF5 mRNA in the patient compared to controls
could not be investigated. The second, is a small 0,3 Mb
duplication harbouring 12 known genes including the
XLMR genes FLNA and GDI1 suggesting a dosage-depend-
ant role for at least one of both genes [42].
Aetiology
In XY males, structural X disomy always results in func-
tional disomy and may be caused either by an intrachro-
mosomal duplication or an unbalanced X/Y or X/
autosome translocation. In females, failure of X chromo-
some dosage compensation could result from a variety of
mechanisms, including an unfavourable pattern of inacti-
vation, a breakpoint separating an X segment from the X-
inactivation centre in cis, or a small ring chromosome.
Intrachromosomal duplications (Figure 1)
Intrachromosomal duplications are the main cause of
functional disomy in males. In most cases, they are inher-
ited and transmitted in families through non-manifesting
mothers. They are very variable in size, location and,
therefore, in gene content. Before the use of array CGH,
only cytogenetically visible duplications of at least 5–10
Mb in size were diagnosed. Duplications encompassing
the X-inactivation centre are subject to inactivation, as in
the rare variant of Klinefelter syndrome with isochromo-
some Xq [43]. An unusual type of intrachromosomal
duplication with the Xq26.3 or Xq27 ->qter region trans-
located to the Xp22.3 band is observed in some cases. It is
usually inherited or may derive from a recombination
within a maternal pericentric inversion. CGH array
allowed detection of far more smaller duplications that
may encompass only one or few genes, or even be asymp-
tomatic [42].
In females, intrachromosomal duplications of X chromo-
some are generally associated with a skewed inactivation
pattern biased towards the duplicated X chromosome
leading to a normal or near normal phenotype (Figure
1c), and they are detected through abnormal offspring.
However, rare cases with a random X inactivation ratio
have also been described in female patients with mental
retardation/multiple congenital anomalies (MR/MCA)
syndromes [44].
Recombination between genomic repeats is a possible
mechanism for the origin of the non-recurrent duplica-
tions. Giglio et al. described four der(X) chromosomes
and proposed recombination between inverted repeat
sequences during paternal meiosis as mechanism of ori-
gin [45]. However, non-recurrent aberrations can result
from different non-exclusive recombination-repair mech-
anisms. The origin and mechanisms underlying some of
the Xq duplications have been investigated in cloning
their breakpoints. Bauters et al. have analysed the break-
points of 16 unique microduplications containing
MECP2 and shown that none of these duplications are the
result of NAHR. They demonstrated non-homologous
end joining (NHEJ) as the mechanism in one of them,
and a complex two-step rearrangement involving break-
age-induced replication with strand invasion of the nor-
mal chromatid in another one [46]. In Pelizaeus-
Merzbacher disease, complex non-recurrent rearrange-
ments are observed that are likely to be caused by a repli-
cation mechanism involving template switching [47].
Translocations (Figure 2)
Duplications resulting from an unbalanced form of X-Y
[t(X;Y)] or X-autosome translocations [t(X;A)] are more
rarely reported, with imbalance limited to the distal por-
tion of Xq.
About six cases of t(X;Y) have been reported in severely
retarded males with non-fluorescent Y chromosome and
translocation of about 10 Mb of Xqter onto Yq. All cases
occurred de novo [5,20,42].
X-autosome translocations [t(X;A)] are rare rearrange-
ments estimated to occur in 1 to 3/10,000 live births [8,9].
Xq duplications resulting from unbalanced t(X;A) have
been observed in males and in females for small terminal
Xq segments translocated onto an acrocentric short arm,
or very distally onto another chromosome arm. In this
type of t(X;A), the autosomal imbalance is absent or very
limited, and does not impact on the phenotype. In
females, the X chromosome segment, separated from the
X-inactivation centre in cis, cannot be inactivated and this
result in functional disomy whatever the inactivated X.
Theoretically, some balanced t(X;A) may result in Xq
functional disomy if the derivative X is inactivated. In any
case, parental karyotypes are required to eliminate an
inherited translocation.
Small X ring chromosomes
Small X ring chromosomes [r(X)] lacking functional XIC
fail to be inactivated. Depending on their gene content,
they may be responsible for FD resulting in a more severe
phenotype than Turner syndrome, with severe mental
retardation [48,49].Orphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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Diagnosis and diagnostic methods
Karyotype
The patients are usually investigated for mental retarda-
tion and a karyotype is performed using banding tech-
niques that detect cytogenetically visible structural
chromosome rearrangement such as large duplications, or
X ring chromosomes. In most cases, the karyotype resolu-
tion is not sufficient, and Xq duplication will be detected
applying additional techniques.
DNA quantitative techniques
DNA techniques such as quantitative PCR (qPCR), multi-
plex ligation-dependent probe amplification (MLPA) or
QM-PSF (quantitative multiplex PCR of short fluorescent)
can be used to detect a targeted Xq duplication, in partic-
ular for the MECP2 or the PLP1 locus.
FISH
FISH (Fluorescence in situ hybridisation) can be used after
an initial diagnosis done by karyotype, and selection of a
specific probe. Nevertheless, diagnosis of duplication
using FISH could be difficult, in particular in prenatal set-
ting. Therefore, quantitative methods are often much bet-
ter ways of detecting small duplications.
Array CGH
Today, CGH array is rapidly becoming the method of
choice to detect small genomic imbalances [50]. This tech-
nique can detect small duplications (few kb) as well as
large duplications (several Mb) allowing description of
more specific phenotypes such as MECP2  duplication
phenotype.
Since 30% more males than females are diagnosed with
mental retardation, full coverage X chromosome CGH-
arrays have been developed for the detection of copy
number alterations in patients with suspected X-linked
mental retardation (XLMR) [51]. Froyen at al. recently
reported a cohort of 108 patients screened using a tiling X-
chromosome-specific genomic array with a theoretical
resolution of 80 kb and detected a total of 15 copy
number changes in 14 patients (13%) that included two
deletions and 13 duplications ranging from 0.1 to 2.7 Mb
harbouring the CDKL5, NXF5, MECP2, and GDI1 genes
[42]. Also, Madrigal et al. detected 26 copy number vari-
ants (CNVs) on 52 patients using X-chromosome tiling
path array [31]. For 8 patients (14,8%) they identified
imbalances probably causative of the phenotype observed
in the patients. In particular, they reported one patient
with Xq12 deletion, one patient with Xq12 duplication
and two patients with Xq28 duplication. The genomic size
of chromosome rearrangement ranged between 82 to 700
kb.
Whole genome CGH arrays with variable resolution are
more generally used to study patients with unexplained
MR/MCA and may lead to an increasing number of Xq
duplication diagnosis.
Molecular X-inactivation studies
X-inactivation studies are required in carrier females. In
the prenatal period and in infants, it may help to the prog-
nosis. For small duplications of uncertain significance
found by CGH array, a random inactivation in an asymp-
tomatic carrier mother argues against a pathogenic effect
of this duplication. X-inactivation studies are most often
done using a PCR protocol based on the methylation sta-
tus of X chromosomes [52]. Alternatively, late replication
assay by cytogenetic methods using BrdU incorporation
distinguishes the two X chromosomes according to their
morphology (normal or rearranged).
Differential diagnosis
Among syndromes presenting clinical features in com-
mon with Xq duplications we will discuss the following:
Prader-Willi syndrome (PWS)
Prader-Willi syndrome (OMIM 176270) affects 1 out of
25,000 births. It is characterised by two periods: I) neona-
tal period with severe hypotonia, characteristic facial fea-
tures, feeding difficulties, hypogenitalism, and small
hands and feet; ii) infancy and adulthood period: hyper-
phagia with a risk of morbid obesity, learning difficulties
and behavioural problems. The expert consensus is that
diagnosis should be based on clinical criteria (Holm's cri-
teria of 1993, revised in 2001 [53]). PWS is caused by
anomalies involving the critical region of chromosome 15
(15q11–q13). The syndrome results from absence of
paternally active gene expression at the 15q11q13 chro-
mosomal region [53]. Phenotypic features of PWS have
previously been reported in association with distal Xq
duplication [2,17,54] and interstitial Xq duplication [19].
It has been suggested that proximal Xq duplications can
result in features typically seen in children and adults with
PWS (obesity and hypogonadism), and duplications dis-
tal to Xq25 to the infantile features of PWS in males
(severe hypotonia, feeding difficulties and hypogenital-
ism) [19].
Alpha-thalassaemia mental retardation
X-linked alpha thalassaemia mental retardation (ATR-X)
syndrome (OMIM 301040) presents with many of the
clinical features found in patients with Xq duplication:
males with profound developmental delay (language is
usually very limited), facial dysmorphism, genital abnor-
malities (in 80% of children, ranging from undescended
testes to ambiguous genitalia). In this syndrome alpha
thalassaemia is occasionally observed. This syndrome isOrphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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X-linked recessive and results from mutations in the ATRX
gene [55].
Genetic counselling
In all cases, parental karyotypes are necessary prior to
genetic counselling. The recurrence risk is significant if a
structural rearrangement is present in one of the parent,
usually the mother. Genetic counselling depends on the
type of chromosomal rearrangement, on the sex of the car-
rier and on the mechanisms potentially leading to func-
tional disomy. Periodic genetic evaluations are warranted
to update parents as more information on this syndrome
becomes available.
Intrachromosomal duplications
The majority of Xq duplications are inherited from a het-
erozygous mother [56]. Most heterozygous females show
extreme to complete skewing of X chromosome inactiva-
tion and thus are asymptomatic. The risk for siblings
depends on the carrier status of the mother.
If the mother is a carrier, the risk of transmitting the dupli-
cation is 50% for each pregnancy (Figure 1). All XY sons
will be affected, daughters will be usually asymptomatic
heterozygous carriers, but may be more or less severely
affected depending on their X-inactivation pattern.
If the duplication had arisen de novo, the recurrence risk
for siblings is not significantly increased when compared
with that of the general population. However, prenatal
diagnosis may be counselled because cryptic or germinal
mosaicism may be present in the mother.
X;Y and X;Autosome translocations
Here again, the risk for siblings depends on the carrier sta-
tus of the parents, with a majority of cases occurring de
novo. Translocation of a small segment of Xq onto Yq
results in all cases in FD and always occurs de novo. X;A
translocations are frequently associated with infertility,
but may be sometimes present in a balanced form in the
mother. In this specific situation, there is a substantial risk
of having abnormal offspring due to an unbalanced chro-
mosomal constitution. In unbalanced X;A translocations,
X-inactivation of the X segment translocated onto the
autosome cannot occur, in females as in males (Figure
2c). The balanced form of the translocation may also be
transmitted to daughters with possible detrimental effect
due to an unfavourable pattern of inactivation. This
requires evaluation of each individual case by a specialist.
Prenatal testing
Prenatal diagnosis with index case
Chromosomal rearrangement can be detected by amnio-
centesis or chorionic villus sampling and cytogenetic test-
ing including FISH and/or DNA quantification as
performed in the propositus. The most frequent situation
is that of an intrachromosomal duplication inherited
from the mother. Prenatal testing may also be done after
diagnosis of a de novo case to exclude germinal mosaicism.
For girls receiving the duplication, the phenotype depends
on X-inactivation pattern. X-inactivation study in prenatal
period is possible, with cautious interpretation. For preg-
nancies in which the mother has been identified as a car-
rier of an interstitial MECP2  duplication, the usual
procedure should be used: determination of foetal sex and
testing for the MECP2 duplication in male. For t(X;A),
careful examination of individual situation is required.
Prenatal diagnosis without index case
Large Xq duplications could be diagnosed by chance after
foetal karyotyping for any reason. No antenatal ultra-
sound signs specific to Xq duplications have been
described.
Management
Individuals with Xq duplication should receive routine
medical care from their primary physician. For symptoms
affecting particular organ systems, specialists should be
consulted. Management is only symptomatic. Patients are
generally treated in the same manner as other patients
presenting the same clinical manifestations, without Xq
duplication. Nevertheless, the increase of knowledge on
the syndrome will support the educational and rehabilita-
tion aid by parents and caregivers.
The swallowing difficulties need an assessment of feeding
in infancy. Early parenteral nutrition could limit postnatal
growth retardation. In fact, various strategies (including
parenteral nutrition) should be investigated to reduce and
if possible, prevent malnutrition [5]. Speech and commu-
nication therapy is essential. Augmentative communica-
tion aids, such as picture cards or communication boards,
should be used at the earliest appropriate time. Elucida-
tion of the type and frequency of seizures is accomplished
by clinical history and electroencephalography. Anticon-
vulsivant medication should be used as for seizures in the
general population.
Major milestones should be evaluated and addressed in a
standard manner, often including a physical therapy eval-
uation. Because of spasticity, physical therapy can help
maintaining joint range of motion and prevent secondary
contractures. Brain MRI could be proposed to detect cere-
bral malformation. In fact, grey matter heterotopia, mild
Dandy-Walker variant, and corpus callosum agenesis have
been reported [29]. The susceptibility of affected males
with Xq28 duplication to respiratory infection raises the
question regarding the use of prophylactic antibiotics. The
use of antibiotics during the winter may be beneficial in
patients with Xq28 duplications [29].Orphanet Journal of Rare Diseases 2009, 4:4 http://www.ojrd.com/content/4/1/4
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Prognosis
As far as we know, the oldest patient reported so far is 30-
years-old. Friez et al. reported that six patients with
MECP2 duplication out of 11 (55%) died before 25 years
of age [29]. Several patients died following infection in
infancy. Malformations do not contribute significantly to
the morbidity associated with this syndrome.
Conclusion
Xq duplications are rare events. Xqter duplications
encompassing the MECP2 gene are the most frequently
detected. These patients present severe mental retardation,
growth retardation, facial dysmorphism, genital hypopla-
sia and recurrent infections. A growing number of Xq
duplications are now described following the widespread
use of array CGH techniques. There is no doubt that new
clinically recognisable syndromes will soon be described,
allowing targeted diagnosis. Candidate genes will emerge
and exploring gene expression in these patients will allow
a better understanding of X-linked mental retardation
mechanisms, including functional disomy.
Support: associations – internet links
A list of groups that support patients, families, and clini-
cians caring for patients with Xq duplications is supplied
in Additional file 1.
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